ArticleInternational journal of molecular sciences2026
Preclinical Evaluation of Combined Polo-like Kinase 1 Inhibition and Navitoclax in Experimental Models of Lung Cancer.
Bárbara Pinto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.